## Investigation of Choice for Suspected Fetal Cardiac Anomaly ### Clinical Context The discrepancy between menstrual age (14 weeks) and biometric age (16 weeks by CRL) suggests either dating error or growth acceleration. More critically, the **small hypoechoic lesion with echogenic rim in the fetal thorax** at this gestational age raises concern for: - **Cardiac rhabdomyoma** (most common fetal cardiac tumor) - **Ventricular septal defect (VSD)** with associated thrombus - **Pericardial effusion** - **Pulmonary sequestration** Given the intrathoracic location and imaging characteristics, a **cardiac etiology** is most likely. ### Why Fetal Echocardiography is the Investigation of Choice **Key Point:** Fetal echocardiography with color Doppler is the gold standard for evaluating any suspected cardiac lesion, anomaly, or dysfunction in utero. It provides real-time assessment of cardiac anatomy, function, and hemodynamics. | Modality | Sensitivity | Specificity | Timing | Hemodynamic Info | |----------|-------------|-------------|--------|------------------| | **2D/3D Ultrasound** | 70–80% | Moderate | Real-time | Limited | | **Fetal Echocardiography** | >95% | >95% | Real-time | Excellent (Doppler) | | **Fetal MRI** | Good | Good | Static | None | | **Postnatal echo** | 100% | 100% | Post-delivery | Complete | **High-Yield:** Fetal echocardiography is **mandatory** for: - Confirmation of suspected cardiac lesions (rhabdomyoma, VSD, AV canal defect) - Assessment of cardiac function and shunt direction (color Doppler) - Screening for associated anomalies (e.g., tuberous sclerosis with rhabdomyoma) - Prognostic counseling and delivery planning. ### Clinical Pearl **Cardiac rhabdomyomas** are the most common fetal cardiac tumor, often associated with **tuberous sclerosis complex (TSC)**. Fetal echocardiography can detect the lesion, assess for hemodynamic compromise (obstruction, regurgitation), and guide counseling. Postnatal screening (skin examination, renal ultrasound, brain imaging) for TSC is essential. **Mnemonic: FETAL ECHO INDICATIONS** — Fetal anomaly suspected, Extracardiac anomalies (VACTERL), Teratogen exposure (lithium, NSAIDs), Arrhythmia, Loss (previous fetal loss), Echo findings on screening (abnormal 4-chamber view). ### Why MRI is Not First-Line Here **MRI is an adjunct** when echocardiography findings are inconclusive or when extracardiac involvement (e.g., mediastinal mass, lung sequestration) needs clarification. It is not the first-line investigation for cardiac lesions. [cite:Callen's Ultrasonography in Obstetrics and Gynecology 6e Ch 14; Copel et al. Fetal Echocardiography 3e] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.